Cat.#: ACPP-1196
| Despition | Insulin Receptor beta Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1019 | Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) | 50 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
| ACPP-1171 | Recombinant Human KCNK9 Protein (Fc Tag) (AC1171) | 50 µg | inquiry |
| ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
| ACPP-1106 | Recombinant Human c-Kit Protein (6×His Tag) (AC1106) | 50 µg | inquiry |
| ACPP-1053 | Recombinant Mouse CD24 Protein (Fc Tag) (AC1053) | 50 µg | inquiry |
| ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1747 | Human TSG Protein (AC1747) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.